Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models
An efficacious HIV vaccine is urgently needed to curb the AIDS pandemic. The modest protection elicited in the phase III clinical vaccine trial in Thailand provided hope that this goal might be achieved. However, new approaches are necessary for further advances. As HIV is transmitted primarily acr...
Main Authors: | Iskra Tuero, Marjorie Robert-Guroff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/6/8/3129 |
Similar Items
-
IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates
by: Sandrine Logerot, et al.
Published: (2021-02-01) -
Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward
by: Parveen Sobia, et al.
Published: (2021-09-01) -
Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens
by: Jonathan S. LeCureux, et al.
Published: (2018-05-01) -
The Development of an AIDS Mucosal Vaccine
by: Xian Tang, et al.
Published: (2010-01-01) -
Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases
by: Frederik W. van Ginkel, et al.
Published: (2000-04-01)